1-2 of 2
Wynne Weston-Davies, MB FRCS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial

Anita Hill, MBChB (Hons), PhD, Wynne Weston-Davies, MB FRCS, Miles Nunn, PhD, Tadeusz Robak, MD PhD, Jerzy Windyga, MD, Andrzej Hellmann, MD PhD DSc, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Agniezka Piekarska, Anna Szmigielska-Kaplon, Morag Griffin, Talha Munir
Journal: Blood
Blood (2017) 130 (Supplement 1): 4747.
https://doi.org/10.1182/blood.V130.Suppl_1.4747.4747
Published: 2017
Journal Articles

Coversin Blocked in Vitro Hemolysis in an Eculizumab-Resistant PNH Patient with the C5 Polymorphism (c.2654G>A)

Yasutaka Ueda, MDPhD, Makiko Osato, DS, Wynne Weston-Davies, MB FRCS, Miles A Nunn, DPhil, Satoru Hayashi, Jun-Ichi Nishimura, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2138.
https://doi.org/10.1182/blood.V126.23.2138.2138
Published: 2015